Month: May 2011

Psych Meds Prevent Artistic and Creative Thought

Not infrequently, at the Bipolar Burble I get comments about how if famous artists with mental illnesses had of been medicated, we would have no art today. For some odd reason their go-to example is always Vincent Van Gogh. Without his untreated mental illness, they argue, Van Gogh wouldn’t have been the great artist we know him to be today.

Right then. Let’s all go off our meds and paint. And chop off our ears.

Read More

Money Through Lies – Direct-to-Consumer Drug Advertising

Making You Want Something You Didn’t Know You Needed

I despise drug ads. No one should be interrupted from watching the season-finale of House only to have a picture of a highly unkempt woman on a couch quickly to be turned into vital young dream girl thanks to the latest wonder-pill. That is absolute poppycock.

But drug companies spent $4.2 billion in 2005 on direct-to-consumer advertising in the US.

Read More

Depressed People Who Take Antidepressants Do Better Long-Term – Part 2

As I mentioned last week, it’s very difficult to measure long-term outcomes of depression treatment due to the confounding depression variables like severity of depression, duration of depression, number of depressions and so on.

In short, the sicker you are, the more depressed you are, the more likely it is you’ll get treatment.

Antidepressant Treatment Outcomes Long-Term, A Study

I discussed the basic outcomes of this study: The association between antidepressant use and depression eight years later: A national cohort study by Colman et al. which tries to take these variables into account.

Colman et al. showed those who took antidepressants had better depression treatment outcomes than those who didn’t, eight years later, once confounding variables were taken into consideration.

I’ll now point out the strengths and weaknesses of this study as well as some other interesting tidbits shown or cited in the study. Oh, and I’ll give my opinion on what it all means.

Read More

Depressed People Who Take Antidepressants Do Better Long-Term

Recently the controversy over long-term outcomes of those who use psychotropic medication has flared up again. Some people argue depression/bipolar/mental illness patients do the same, or better, when they don’t take psychiatric medications long-term. However, the statistics they use to assert this claim are often faulty.

A study from Calgary, Alberta, Canada (yes, we do research up here too) has attempted to fix some of the bias seen in other long-term depression treatment outcome statistics. I’ll cut to the chase for you:

Over the course of eight years people with depression who took antidepressants had better outcomes.

Read More

Control Over Bipolar Treatment – Learned Helplessness

One of the crazy things that will happen to you when you seek treatment for being crazy, is doctors will ask you what treatment you want. Usually your psychiatrist/doctor will give you two options: Would you like to try psych med A or psych med B? This provides the mirage of control over your mental illness and your mental illness treatment.

Frustration, thy name is bipolar.

Patients Choosing Psych Meds has an Air of Hilarity to It

This choice, of course, is ridiculous.* How should you know which medication to pick? They’re the doctor, the fancy psychiatrist, aren’t they supposed to know?

What criterion could you possibly use to pick a psychotropic medication that would conceivably compare to an actual doctor?

Read More
Get Natasha Tracy's Book

Subscribe to the Burble via Email

Additional Writings

Check out my Amazon Author Page.

I write a three-time Web Health Award winning column for HealthyPlace called Breaking Bipolar.

Also, find my writings on The Huffington Post and my work for BPHope (BP Magazine).

Archives

Subscribe for a FREE EBook!

Subscribe for a FREE EBook!

Subscribe to my monthly newsletter to get the latest from Bipolar Burble, Breaking Bipolar, my vlogs at bpHope, my masterclasses, and other useful tidbits -- plus get a FREE eBook on coping skills.

Thank you for subscribing. Look for an email to complete your subscription.